开云app官网登录入口网页版-官方正版

#EMA#

580篇内容 | 5137人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1317752, encodeId=36b0131e75206, content=<a href='/topic/show?id=74916e0414' target=_blank style='color:#2F92EE;'>#EMA#</a>, objectTitle=Castleman病：症状与体征、病因、流行病学、诊断与治疗, objectType=article, longId=739349, objectId=dbf7e393498d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=dbf7e393498d, replyNumber=0, likeNumber=135, createdTime=2022-09-16, rootId=0, userName=fengyi812, userId=a35a460, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=dbf7e393498d, moduleTitle=Castleman病：症状与体征、病因、流行病学、诊断与治疗, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=dbf7e393498d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1317751, encodeId=480f131e75163, content=<a href='/topic/show?id=74916e0414' target=_blank style='color:#2F92EE;'>#EMA#</a>, objectTitle=Lancet Haematol：Tisagenlecleucel在急性淋巴细胞白血病幼儿和婴儿患者中的临床真实数据, objectType=article, longId=738557, objectId=cac4e385573d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=cac4e385573d, replyNumber=0, likeNumber=121, createdTime=2022-09-09, rootId=0, userName=fengyi812, userId=a35a460, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=cac4e385573d, moduleTitle=Lancet Haematol：Tisagenlecleucel在急性淋巴细胞白血病幼儿和婴儿患者中的临床真实数据, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=cac4e385573d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1317749, encodeId=1d2f131e7493c, content=<a href='/topic/show?id=74916e0414' target=_blank style='color:#2F92EE;'>#EMA#</a>, objectTitle=Hematology：艾沙康唑预防血液学环境中侵袭性真菌感染的有效性和安全性, objectType=article, longId=738349, objectId=9309e3834970, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9309e3834970, replyNumber=0, likeNumber=80, createdTime=2022-09-07, rootId=0, userName=fengyi812, userId=a35a460, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9309e3834970, moduleTitle=Hematology：艾沙康唑预防血液学环境中侵袭性真菌感染的有效性和安全性, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=9309e3834970)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1317750, encodeId=6ed4131e7509e, content=<a href='/topic/show?id=74916e0414' target=_blank style='color:#2F92EE;'>#EMA#</a>, objectTitle=Hematology：重度再生障碍性贫血小儿异基因造血干细胞移植受者不同移植来源和条件下出血性膀胱炎的结局和危险因素, objectType=article, longId=737614, objectId=1c25e376149f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1c25e376149f, replyNumber=0, likeNumber=80, createdTime=2022-09-03, rootId=0, userName=fengyi812, userId=a35a460, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1c25e376149f, moduleTitle=Hematology：重度再生障碍性贫血小儿异基因造血干细胞移植受者不同移植来源和条件下出血性膀胱炎的结局和危险因素, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=1c25e376149f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1317746, encodeId=1b1c131e746a5, content=<a href='/topic/show?id=74916e0414' target=_blank style='color:#2F92EE;'>#EMA#</a>, objectTitle=辉瑞/BioNTech向FDA和EMA提交二价奥密克戎特异性mRNA疫苗上市申请, objectType=article, longId=736670, objectId=313be36670fc, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=313be36670fc, replyNumber=0, likeNumber=125, createdTime=2022-08-24, rootId=0, userName=fengyi812, userId=a35a460, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=313be36670fc, moduleTitle=辉瑞/BioNTech向FDA和EMA提交二价奥密克戎特异性mRNA疫苗上市申请, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=313be36670fc)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1317747, encodeId=58a8131e7479b, content=<a href='/topic/show?id=74916e0414' target=_blank style='color:#2F92EE;'>#EMA#</a>, objectTitle= Lancet Haematol：非贫血性缺铁与择期心脏手术 (IDOCS) 后结果之间的关联：一项前瞻性队列研究, objectType=article, longId=736668, objectId=d7b9e3666870, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d7b9e3666870, replyNumber=0, likeNumber=113, createdTime=2022-08-24, rootId=0, userName=fengyi812, userId=a35a460, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d7b9e3666870, moduleTitle= Lancet Haematol：非贫血性缺铁与择期心脏手术 (IDOCS) 后结果之间的关联：一项前瞻性队列研究, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=d7b9e3666870)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1317745, encodeId=3ace131e74591, content=<a href='/topic/show?id=74916e0414' target=_blank style='color:#2F92EE;'>#EMA#</a>, objectTitle=Int J Hematol：患有血液和肿瘤疾病的住院儿童计划外拔除中心静脉导管的危险因素, objectType=article, longId=736455, objectId=efb5e36455d0, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=efb5e36455d0, replyNumber=0, likeNumber=92, createdTime=2022-08-22, rootId=0, userName=fengyi812, userId=a35a460, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=efb5e36455d0, moduleTitle=Int J Hematol：患有血液和肿瘤疾病的住院儿童计划外拔除中心静脉导管的危险因素, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=efb5e36455d0)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1317744, encodeId=d613131e744e1, content=<a href='/topic/show?id=74916e0414' target=_blank style='color:#2F92EE;'>#EMA#</a>, objectTitle=Ann Hematol ：将血小板计数阈值降低至 10,000/µL 以安全地保存血液制品, objectType=article, longId=735488, objectId=6e0ce354885f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6e0ce354885f, replyNumber=0, likeNumber=144, createdTime=2022-08-11, rootId=0, userName=fengyi812, userId=a35a460, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6e0ce354885f, moduleTitle=Ann Hematol ：将血小板计数阈值降低至 10,000/µL 以安全地保存血液制品, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=6e0ce354885f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1317742, encodeId=cc58131e742a7, content=<a href='/topic/show?id=74916e0414' target=_blank style='color:#2F92EE;'>#EMA#</a>, objectTitle=NEJM：cinpanemab治疗早期帕金森病失败, objectType=article, longId=734862, objectId=5e7de34862d3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5e7de34862d3, replyNumber=0, likeNumber=123, createdTime=2022-08-06, rootId=0, userName=fengyi812, userId=a35a460, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5e7de34862d3, moduleTitle=NEJM：cinpanemab治疗早期帕金森病失败, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=5e7de34862d3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1317743, encodeId=11df131e74393, content=<a href='/topic/show?id=74916e0414' target=_blank style='color:#2F92EE;'>#EMA#</a>, objectTitle=【Haematologica】40年来，7+3诱导方案治疗AML的临床结局改善情况, objectType=article, longId=734611, objectId=9331e346111d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9331e346111d, replyNumber=0, likeNumber=90, createdTime=2022-08-06, rootId=0, userName=fengyi812, userId=a35a460, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9331e346111d, moduleTitle=【Haematologica】40年来，7+3诱导方案治疗AML的临床结局改善情况, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=9331e346111d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1317741, encodeId=5cb8131e74167, content=<a href='/topic/show?id=74916e0414' target=_blank style='color:#2F92EE;'>#EMA#</a>, objectTitle=Ann Hematol ：外周插入的中心静脉导管可减少与中心线相关的血流感染并改变成人血液学单元的微生物流行病学：倾向评分调整分析, objectType=article, longId=732736, objectId=e8b7e3273695, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e8b7e3273695, replyNumber=0, likeNumber=130, createdTime=2022-07-20, rootId=0, userName=fengyi812, userId=a35a460, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e8b7e3273695, moduleTitle=Ann Hematol ：外周插入的中心静脉导管可减少与中心线相关的血流感染并改变成人血液学单元的微生物流行病学：倾向评分调整分析, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=e8b7e3273695)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1317740, encodeId=7390131e74021, content=<a href='/topic/show?id=74916e0414' target=_blank style='color:#2F92EE;'>#EMA#</a>, objectTitle= Acta Haematol：阿扎胞苷、维奈托克和曲美替尼在携带 RAS 通路激活突变的复发或难治性 AML 中的 II 期研究结果, objectType=article, longId=731496, objectId=0687e314968e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0687e314968e, replyNumber=0, likeNumber=92, createdTime=2022-07-08, rootId=0, userName=fengyi812, userId=a35a460, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0687e314968e, moduleTitle= Acta Haematol：阿扎胞苷、维奈托克和曲美替尼在携带 RAS 通路激活突变的复发或难治性 AML 中的 II 期研究结果, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=0687e314968e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1317739, encodeId=7c75131e73922, content=<a href='/topic/show?id=74916e0414' target=_blank style='color:#2F92EE;'>#EMA#</a>, objectTitle=Hematol Oncol：诊断为弥漫性大 B 细胞淋巴瘤并接受蒽环类药物治疗的患者心血管事件和死亡率的危险因素, objectType=article, longId=731395, objectId=ba22e3139533, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ba22e3139533, replyNumber=0, likeNumber=81, createdTime=2022-07-07, rootId=0, userName=fengyi812, userId=a35a460, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ba22e3139533, moduleTitle=Hematol Oncol：诊断为弥漫性大 B 细胞淋巴瘤并接受蒽环类药物治疗的患者心血管事件和死亡率的危险因素, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=ba22e3139533)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1317738, encodeId=1f88131e738cc, content=<a href='/topic/show?id=74916e0414' target=_blank style='color:#2F92EE;'>#EMA#</a>, objectTitle= Ann Hematol：血液系统恶性肿瘤患者的低细胞膜通透性介导口服来那度胺的低脑脊液与血浆比率, objectType=article, longId=731292, objectId=7b9ee31292d1, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7b9ee31292d1, replyNumber=0, likeNumber=119, createdTime=2022-07-06, rootId=0, userName=fengyi812, userId=a35a460, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7b9ee31292d1, moduleTitle= Ann Hematol：血液系统恶性肿瘤患者的低细胞膜通透性介导口服来那度胺的低脑脊液与血浆比率, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=7b9ee31292d1)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1317737, encodeId=e248131e73751, content=<a href='/topic/show?id=74916e0414' target=_blank style='color:#2F92EE;'>#EMA#</a>, objectTitle=HAEMATOLOGICA：戊型肝炎感染对血液病患者肿瘤治疗方法的影响, objectType=article, longId=731195, objectId=5c41e3119554, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5c41e3119554, replyNumber=0, likeNumber=94, createdTime=2022-07-05, rootId=0, userName=fengyi812, userId=a35a460, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5c41e3119554, moduleTitle=HAEMATOLOGICA：戊型肝炎感染对血液病患者肿瘤治疗方法的影响, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=5c41e3119554)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1317736, encodeId=0004131e7369e, content=<a href='/topic/show?id=74916e0414' target=_blank style='color:#2F92EE;'>#EMA#</a>, objectTitle=Ann Hematol：吉列替尼单药治疗复发/难治性 FLT3 突变急性髓细胞白血病的真实世界研究, objectType=article, longId=730781, objectId=f847e307815e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f847e307815e, replyNumber=0, likeNumber=122, createdTime=2022-06-30, rootId=0, userName=fengyi812, userId=a35a460, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f847e307815e, moduleTitle=Ann Hematol：吉列替尼单药治疗复发/难治性 FLT3 突变急性髓细胞白血病的真实世界研究, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=f847e307815e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1317735, encodeId=06bc131e735d5, content=<a href='/topic/show?id=74916e0414' target=_blank style='color:#2F92EE;'>#EMA#</a>, objectTitle= Hematol Oncol：鲁索替尼联合强的松、沙利度胺和达那唑治疗骨髓纤维化患者可减少贫血和血小板减少症发生, objectType=article, longId=729566, objectId=040ce2956646, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=040ce2956646, replyNumber=0, likeNumber=84, createdTime=2022-06-16, rootId=0, userName=fengyi812, userId=a35a460, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=040ce2956646, moduleTitle= Hematol Oncol：鲁索替尼联合强的松、沙利度胺和达那唑治疗骨髓纤维化患者可减少贫血和血小板减少症发生, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=040ce2956646)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1317734, encodeId=e4fb131e73462, content=<a href='/topic/show?id=74916e0414' target=_blank style='color:#2F92EE;'>#EMA#</a>, objectTitle=A&R：Semaphorin 3B在血清诱导的关节炎模型中的中心作用和在类风湿关节炎患者的水平降低, objectType=article, longId=729245, objectId=e07ae2924507, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e07ae2924507, replyNumber=0, likeNumber=80, createdTime=2022-06-15, rootId=0, userName=fengyi812, userId=a35a460, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e07ae2924507, moduleTitle=A&R：Semaphorin 3B在血清诱导的关节炎模型中的中心作用和在类风湿关节炎患者的水平降低, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=e07ae2924507)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1317733, encodeId=108e131e733f1, content=<a href='/topic/show?id=74916e0414' target=_blank style='color:#2F92EE;'>#EMA#</a>, objectTitle=Ann Hematol：强化免疫抑制疗法联合脐带血治疗重度再生障碍性贫血的多中心试验, objectType=article, longId=729121, objectId=427be2912122, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=427be2912122, replyNumber=0, likeNumber=108, createdTime=2022-06-12, rootId=0, userName=fengyi812, userId=a35a460, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=427be2912122, moduleTitle=Ann Hematol：强化免疫抑制疗法联合脐带血治疗重度再生障碍性贫血的多中心试验, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=427be2912122)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1317732, encodeId=301b131e732b6, content=<a href='/topic/show?id=74916e0414' target=_blank style='color:#2F92EE;'>#EMA#</a>, objectTitle=Ann Hematol：福沙匹坦联合托烷司琼和奥氮平多日给药可改善自体造血干细胞移植前接受化疗的患者恶心和呕吐, objectType=article, longId=729119, objectId=ba9ee291193d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ba9ee291193d, replyNumber=0, likeNumber=97, createdTime=2022-06-12, rootId=0, userName=fengyi812, userId=a35a460, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ba9ee291193d, moduleTitle=Ann Hematol：福沙匹坦联合托烷司琼和奥氮平多日给药可改善自体造血干细胞移植前接受化疗的患者恶心和呕吐, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=ba9ee291193d)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 风湿免疫小助手

EMA

2020-05-29

fengyi812 (审核中...)

前往app查看评论内容

#EMA#

Castleman病：症状与体征、病因、流行病学、诊断与治疗

2022-09-16

fengyi812 (审核中...)

前往app查看评论内容

#EMA#

Lancet Haematol：Tisagenlecleucel在急性淋巴细胞白血病幼儿和婴儿患者中的临床真实数据

2022-09-09

fengyi812 (审核中...)

前往app查看评论内容

#EMA#

Hematology：艾沙康唑预防血液学环境中侵袭性真菌感染的有效性和安全性

2022-09-07

fengyi812 (审核中...)

前往app查看评论内容

#EMA#

Hematology：重度再生障碍性贫血小儿异基因造血干细胞移植受者不同移植来源和条件下出血性膀胱炎的结局和危险因素

2022-09-03

fengyi812 (审核中...)

前往app查看评论内容

#EMA#

辉瑞/BioNTech向FDA和EMA提交二价奥密克戎特异性mRNA疫苗上市申请

2022-08-24

fengyi812 (审核中...)

前往app查看评论内容

#EMA#

Lancet Haematol：非贫血性缺铁与择期心脏手术 (IDOCS) 后结果之间的关联：一项前瞻性队列研究

2022-08-24

fengyi812 (审核中...)

前往app查看评论内容

#EMA#

Int J Hematol：患有血液和肿瘤疾病的住院儿童计划外拔除中心静脉导管的危险因素

2022-08-22

fengyi812 (审核中...)

前往app查看评论内容

#EMA#

Ann Hematol ：将血小板计数阈值降低至 10,000/µL 以安全地保存血液制品

2022-08-11

fengyi812 (审核中...)

前往app查看评论内容

#EMA#

NEJM：cinpanemab治疗早期帕金森病失败

2022-08-06

fengyi812 (审核中...)

前往app查看评论内容

#EMA#

【Haematologica】40年来，7+3诱导方案治疗AML的临床结局改善情况

2022-08-06

fengyi812 (审核中...)

前往app查看评论内容

#EMA#

Ann Hematol ：外周插入的中心静脉导管可减少与中心线相关的血流感染并改变成人血液学单元的微生物流行病学：倾向评分调整分析

2022-07-20

fengyi812 (审核中...)

前往app查看评论内容

#EMA#

Acta Haematol：阿扎胞苷、维奈托克和曲美替尼在携带 RAS 通路激活突变的复发或难治性 AML 中的 II 期研究结果

2022-07-08

fengyi812 (审核中...)

前往app查看评论内容

#EMA#

Hematol Oncol：诊断为弥漫性大 B 细胞淋巴瘤并接受蒽环类药物治疗的患者心血管事件和死亡率的危险因素

2022-07-07

fengyi812 (审核中...)

前往app查看评论内容

#EMA#

Ann Hematol：血液系统恶性肿瘤患者的低细胞膜通透性介导口服来那度胺的低脑脊液与血浆比率

2022-07-06

fengyi812 (审核中...)

前往app查看评论内容

#EMA#

HAEMATOLOGICA：戊型肝炎感染对血液病患者肿瘤治疗方法的影响

2022-07-05

fengyi812 (审核中...)

前往app查看评论内容

#EMA#

Ann Hematol：吉列替尼单药治疗复发/难治性 FLT3 突变急性髓细胞白血病的真实世界研究

2022-06-30

fengyi812 (审核中...)

前往app查看评论内容

#EMA#

Hematol Oncol：鲁索替尼联合强的松、沙利度胺和达那唑治疗骨髓纤维化患者可减少贫血和血小板减少症发生

2022-06-16

fengyi812 (审核中...)

前往app查看评论内容

#EMA#

A&R：Semaphorin 3B在血清诱导的关节炎模型中的中心作用和在类风湿关节炎患者的水平降低

2022-06-15

fengyi812 (审核中...)

前往app查看评论内容

#EMA#

Ann Hematol：强化免疫抑制疗法联合脐带血治疗重度再生障碍性贫血的多中心试验

2022-06-12

fengyi812 (审核中...)

前往app查看评论内容

#EMA#

Ann Hematol：福沙匹坦联合托烷司琼和奥氮平多日给药可改善自体造血干细胞移植前接受化疗的患者恶心和呕吐

2022-06-12

科室
- - 订阅+
  - 更多科室
工具
服务